Biodegradable gel boosts immune system's attack on several cancers in mice
A new biodegradable gel improves the immune system's ability to keep cancer at bay after tumors are surgically removed.
Apr 6, 2022
0
76
A new biodegradable gel improves the immune system's ability to keep cancer at bay after tumors are surgically removed.
Apr 6, 2022
0
76
Houston Methodist researchers have identified the genetic and molecular fingerprints of different cancer and immune cells in glioblastoma, the deadliest and most common type of brain cancer in adults.
Apr 5, 2022
0
39
Findings from a new study performed in mice suggest that omega-3 fatty acids could help immunotherapy and other treatments do a better job at fighting cancer. Immunotherapies, which stimulate the body's own immune system ...
Apr 1, 2022
0
17
Hokkaido University scientists have identified new targets for treating an aggressive form of adult leukemia with existing drugs. The findings were published in the journal Blood.
Mar 31, 2022
0
81
Treatment for glioma has long relied on MRI imaging to track tumor markers and treatment response. But findings from a team at the University of Michigan Rogel Cancer Center, led by Carl Koschmann, M.D., pediatric neuro-oncologist ...
Mar 24, 2022
0
30
An international team of researchers has found that some cancer cells are able to make up for a loss of tryptophan by conducting codon reassignments that allow for the production of phenylalanine "substitutants" (a word they ...
A combination therapy that targets cancer cells from within and without caused tumors to shrink or stabilize in 75% of patients with recurrent or persistent estrogen receptor- (ER-) positive endometrial cancer, results from ...
Mar 20, 2022
0
94
Tumors can use an enzyme called ART1 to thwart antitumor immune cells, making the enzyme a promising new target for immunity-boosting cancer treatments, according to a study from researchers at Weill Cornell Medicine andĀ Albert ...
Mar 16, 2022
0
57
Researchers at the University of California, San Francisco, have successfully leveraged an FDA-approved drug to halt growth of tumors driven by mutations in the RAS gene, which are famously difficult to treat and account ...
Mar 9, 2022
0
5
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) has discovered a new immune checkpoint that may be exploited for cancer therapy.
Mar 8, 2022
1
111